Tuesday, August 21, 2018 9:35:33 AM
International Battery Metals Ltd. Retains IMPACT Technology Development to Design Engineer and Build Its First Mobile Petro-Lithium Extraction Unit Vancouver, British Columbia--(Newsfile Corp. - August 20, 2018) - International Battery Metals Ltd. (CSE: IBAT) ("IBAT" or the "Company"), has retained IMPACT Technology Development ("IMPACT") to help facilitate the engineering, design, and construction of its first proprietary mobile lithium extraction unit. IMPACT has a qualified team of chemical engineers and chemists who specialize in developing, scaling-up, and commercializing chemical process technologies. Their services range from research and lab pilot testing in their R&D facility in Devens, MA through to a full commercial scale engineering design package ready for engineering procurement and construction implementation. Their unique "one-stop-shop" of process development & engineering services has helped over 250 clients in the last 20 years launch their new process technologies worldwide. "We are very excited to be partnering with International Battery Metals in the development and commercialization of their Lithium recovery process from oil field brines," commented Mark Wilkinson, President of IMPACT. "This innovative technology will provide a new, untapped source of high grade Lithium for the rapidly growing world market. We are looking forward to being a part of the IBAT team." John Burba stated, "After evaluating numerous engineering firms, we have selected Impact Technology Development to partner with us in the development and deployment of our Mobile Extraction Unit technology. Impact has a very impressive group of chemists and chemical engineers that have many years of individual and collective experience. We look forward to a long and fruitful relationship." At the AGM held on August 14, 2018 in Denver Colorado USA, the shareholders approved all the items on the agenda. The board of directors now consists of Dr. John Burba CEO, President, COB, Logan Anderson CFO, David Scott, David Ryan and Scott Young
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM